Loading ...

Vaginal Microbiome Exposure and Immune Responses in C-section Infants

(

ACTIVATE

)

ITN Protocol #:

ITN079AD

Branded Name:

ACTIVATE

ClinicalTrials.Gov ID:

NCT03567707

Treatment Protocol #:

Therapeutic Area:

Allergy & Asthma

Current Status:

Follow-up

Summary:

Exposure to Vaginal Microbiome in C-section Infants at High-risk for Allergies - A Pilot Study

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

NIAID Regulator Officer

Rho Data Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Hugh Sampson, MDhugh.sampson@mssm.edu

Work: 

212-241-5548

Protocol Chair

Jose C. Clemente, PhDjose.clemente@mssm.edu

Work: 

212-824-8952

Protocol Chair

Audrey Ploughaplough@immunetolerance.org

Work: 

415-278-0709

Protocol Chair

Carolyn Bromsteadcbromstead@immunetolerance.org

Work: 

415-278-0702

Protocol Chair

Carolyn Baloh, MDcbaloh@immunetolerance.org

Work: 

412-508-5216

Protocol Chair

Sharon Chung, MDschung@immunetolerance.org

Work: 

415-610-7319

Protocol Chair

Ling Li, PhDlil16@niaid.nih.gov

Work: 

240-627-3765

Protocol Chair

LaSonia MorganLaSonia_Morgan@rhoworld.com

Work: 

919-595-6379

Protocol Chair

Lars Dunaway, PhDLars_Dunaway@rhoworld.com

Work: 

(919) 595-6382